The Board of Directors of the Company and all Directors guarantee that the content of this announcement does not contain any false records, misleading statements, or major omissions, and bear individual and joint responsibility for the authenticity, accuracy, and completeness of its content.
Securities Code: 002007
Securities Abbreviation: Hualan Biological
Announcement Number: 2026-023
Hualan Biological Engineering Co., Ltd. (hereinafter referred to as "the Company") announces the completion of the repurchase and cancellation of certain restricted stocks.
Special Reminder:
(1) The repurchase and cancellation of restricted stocks involves 83 incentive recipients, with a total of 1,765,680 shares repurchased, accounting for 0.0966% of the total shares of 1,827,456,666 prior to the repurchase.
(2) The repurchase price of the restricted stocks is 9.89 yuan.
(3) As of the date of this announcement, the Company has completed the repurchase and cancellation procedures for the above-mentioned restricted stocks at the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. After the completion of the repurchase and cancellation, the total share capital of the Company will decrease from 1,827,456,666 shares to 1,825,690,986 shares. The Company will handle the relevant industrial and commercial change registration procedures in accordance with the law.
Hualan Biological Engineering Co., Ltd. (hereinafter referred to as "the Company") held the fourth meeting of the ninth Board of Directors on March 27, 2026, and the annual shareholders' meeting for 2025 on April 20, 2026, where it reviewed and approved the proposal on the repurchase and cancellation of certain restricted stocks under the 2023 Restricted Stock Incentive Plan and the adjustment of the repurchase price. The specific content can be found in the announcement disclosed by the Company on March 28, 2026, in the Securities Times and the Giant Tide Information Network (Announcement Number: 2026-007).
The Company completed the repurchase and cancellation procedures for the above-mentioned restricted stocks on May 25, 2026, and hereby announces the following matters: